Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel JB, Corot C, Ballet S.
Ouimet T, et al. Among authors: duquesnoy s.
Mol Pharm. 2012 Apr 2;9(4):850-61. doi: 10.1021/mp2003863. Epub 2012 Mar 8.
Mol Pharm. 2012.
PMID: 22352457